Prevalence, Detection, and Management of the Metabolic Syndrome in Patients with Acute Myocardial Infarction: Role of an Obesity-Centric Definition

Background. We sought to determine and compare the prevalence of the Metabolic Syndrome (MS) in patients with acute myocardial infarction (AMI) utilizing the new International Diabetes Federation (IDF) definition with the older National Cholesterol Education Program (NCEP) definition. We also examined the clinical utility of MS in this context. Methods. A total of 107 consecutive patients with AMI were prospectively evaluated for MS. Fasting lipids obtained at admission and fasting glucose at discharge were used. A postdischarge folder audit verified rates of discharge coding and implementation of specific management strategies for MS. Results. Baseline patient characteristics included: mean age 59 ± 13 years; males 80%; diabetes 19%; mean BMI 29.7 ± 8.4 kg/m2. MS prevalence was 54% by the IDF definition and 49% by the NCEP definition, with good agreement between definitions: κ = 0.664, P < .001. Factors predictive of MS after multivariate analysis included: hypertension, fasting glucose, waist circumference, and serum HDL (all P < .05). Despite the high prevalence, MS was recognized at discharge in only 1 patient, and referral for exercise and/or weight-loss programs was undertaken in 5 patients. Conclusion. There is a high prevalence of MS utilizing contemporary definitions in patients with AMI: 54% by the IDF definition and 49% by NCEP criteria. Despite the high prevalence, MS was under-recognized and under-treated in this population.

• Publication year

  2010

• Venue

  Cardiology Research and Practice

• Publication date

  2010-07-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.4061/2010/814561PMID 20811489PMCID 2926676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Standards of Medical Care in Diabetes—2012

  2011cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Metabolic Syndrome Pandemic

  2008cited by this paper
• Should we dump the metabolic syndrome? No

  2008cited by this paper
• Left ventricular diastolic dysfunction in normotensive diabetic patients in various age strata.

  2008cited by this paper
• Prevalence of metabolic syndrome in patients < or =45 years of age with acute myocardial infarction having percutaneous coronary intervention.

  2007cited by this paper
• The metabolic syndrome—does it exist?

  2007cited by this paper
• The metabolic syndrome in Australia: prevalence using four definitions.

  2007cited by this paper
• Metabolic Syndrome: Is It a Syndrome? Does It Matter?

  2007cited by this paper
• Guidelines for the management of acute coronary syndromes 2006

  2006cited by this paper
• Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation

  2006cited by this paper
• Redefinition of the metabolic syndrome--useful or creating illness?

  2006cited by this paper
• Guidelines for the management of acute coronary syndromes 2006

  2006cited by this paper
• Standards of Medical Care in Diabetes: Response to Power

  2006cited by this paper
• Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus.

  2005cited by this paper
• The metabolic syndrome--a new worldwide definition.

  2005cited by this paper
• National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study

  2004influential reference
• ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients Wi

  2004cited by this paper
• Standards of medical care in diabetes.

  2004cited by this paper
• Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes.

  2003cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction.

  2002cited by this paper
• Cardiovascular morbidity and mortality associated with the metabolic syndrome.

  2001influential reference
• Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

  2000cited by this paper
• Obesity : Preventing and managing the global epidemic

  2000cited by this paper
• Banting lecture 1988

  1997cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• How soon after myocardial infarction should plasma lipid values be assessed?

  1985cited by this paper
• How soon after myocardial infarction should plasma lipid values be assessed?

  1984cited by this paper

• The Effect and Prevalence of Comorbidities in Adolescents With CKD and Obesity.

  2022cites this paper
• Left Ventricular Electromechanical Remodeling Detected by Acoustic Cardiography in Paroxysmal Atrial Fibrillation

  2020cites this paper
• Obesity as Behavioral Risk Factors of Chronic Noncommunicable Diseases in Young Gabonese Population

  2020cites this paper
• Study of Clinical and Biochemical Profile of Metabolic Syndrome in Acute Myocardial Infarction

  2019cites this paper
• Atrial dysplasia in the atria of humans without cardiovascular disease

  2019cites this paper
• Cardiac arrest due to critical stenosis of a bicuspid aortic valve mimicking left main coronary artery occlusion on ECG

  2018cites this paper
• Systematic review: safety of mesalazine in ulcerative colitis

  2018cites this paper
• Concurrent Sweet’s syndrome and myopericarditis following mesalamine therapy

  2018cites this paper
• Components Analysis of Metabolic Syndrome in Acute Myocardial Infarction Patients

  2018cites this paper
• Accuracy of 12 Lead ECG For Diagnosis of Posterior Myocardial Infarction Taking 15 Lead ECG As Gold Standard

  2018cites this paper
• Incidence of Metabolic Syndrome in Patients Admitted to Medical Wards with ST Elevation Myocardial Infarction.

  2017cites this paper
• Can we win the war on obesity with pharmacotherapy?

  2016cites this paper
• Increased Perforation Risk with an MRI‐Conditional Pacing Lead: A Single‐Center Study

  2015cites this paper
• Effects of dietary supplementation with pure natural honey on metabolism in growing Sprague-Dawley rats.

  2014influential citation
• Prevalence of the metabolic syndrome using two proposed definitions in a Japanese-Brazilians community

  2012cites this paper
• Treatment-emergent adverse events associated with atypical antipsychotics

  2012cites this paper
• Metabolic Syndrome and Renal Injury

  2011cites this paper
• Prevalence of preexisting metabolic syndrome as defined by Japanese original criteria among patients with non-fatal myocardial infarction.

  2011cites this paper